SEC 13F Intelligence

Grantham, Mayo, Van Otterloo & Co. LLC / ABT

Grantham, Mayo, Van Otterloo & Co. LLC’s Abbott Laboratories Position

Does Grantham, Mayo, Van Otterloo & Co. LLC own Abbott Laboratories (ABT)? Yes — 8.91M shares worth $915M (+2.34% of its 13F portfolio) as of Q1 2026, up from 8.48M shares the prior filed quarter.

Position Value
$915M
Q1 2026
Shares
8.91M
% of Portfolio
+2.34%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $146MQ4 ’18Q1 ’19: $147MQ2 ’19: $147MQ3 ’19: $151MQ4 ’19: $157MQ4 ’19Q1 ’20: $115MQ2 ’20: $110MQ3 ’20: $208MQ4 ’20: $195MQ4 ’20Q1 ’21: $207MQ2 ’21: $201MQ3 ’21: $207MQ4 ’21: $238MQ4 ’21Q1 ’22: $195MQ2 ’22: $175MQ3 ’22: $160MQ4 ’22: $180MQ4 ’22Q1 ’23: $167MQ2 ’23: $312MQ3 ’23: $355MQ4 ’23: $482MQ4 ’23Q1 ’24: $615MQ2 ’24: $602MQ3 ’24: $811MQ4 ’24: $893MQ4 ’24Q1 ’25: $1.1BQ2 ’25: $1.1BQ3 ’25: $1.1BQ4 ’25: $1.1BQ4 ’25Q1 ’26: $915Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20268.91M$915M+2.34%
Q4 20258.48M$1.1B+2.72%
Q3 20258.18M$1.1B+3.09%
Q2 20257.81M$1.1B+3.20%
Q1 20258.11M$1.1B+3.39%
Q4 20247.90M$893M+2.91%
Q3 20247.11M$811M+2.54%
Q2 20245.79M$602M+2.03%
Q1 20245.41M$615M+2.23%
Q4 20234.38M$482M+2.13%
Q3 20233.66M$355M+1.68%
Q2 20232.86M$312M+1.45%
Q1 20231.65M$167M+0.85%
Q4 20221.64M$180M+0.96%
Q3 20221.65M$160M+0.92%
Q2 20221.61M$175M+0.95%
Q1 20221.65M$195M+0.94%
Q4 20211.69M$238M+1.14%
Q3 20211.76M$207M+1.03%
Q2 20211.73M$201M+1.00%
Q1 20211.72M$207M+1.13%
Q4 20201.78M$195M+1.20%
Q3 20201.91M$208M+1.48%
Q2 20201.20M$110M+0.81%
Q1 20201.45M$115M+0.96%
Q4 20191.81M$157M+1.05%
Q3 20191.80M$151M+1.05%
Q2 20191.75M$147M+1.03%
Q1 20191.84M$147M+1.06%
Q4 20182.02M$146M+1.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Grantham, Mayo, Van Otterloo & Co. LLC’s full portfolio or all institutional holders of ABT.